Literature DB >> 15853619

Angiotensin and Alzheimer's disease: therapeutic prospects.

Paul R Gard1, Jennifer M Rusted.   

Abstract

This review describes the features of Alzheimer's disease and discusses the evidence that antihypertensive therapies may be beneficial in its treatment and prevention. Drugs acting via the renin-angiotensin system are considered and it is suggested that these drugs may produce their effects via mechanisms other than by their antihypertensive actions. Using evidence from animal studies, the role of angiotensin as a neurotransmitter and its involvement in the control of normal cognitive function is described. Studies of angiotensin and human cognition are reviewed along with studies investigating the possible link between disorders of the system, either inherited or acquired, and the symptoms of Alzheimer's disease. The therapeutic potential of screening for markers of renin-angiotensin abnormality for the prediction of Alzheimer's disease is considered, as is the potential use of agents known to influence the renin-angiotensin system in the treatment or prevention of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15853619     DOI: 10.1586/14737175.4.1.87

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  8 in total

Review 1.  Alzheimer's disease and age-related memory decline (preclinical).

Authors:  Alvin V Terry; Patrick M Callahan; Brandon Hall; Scott J Webster
Journal:  Pharmacol Biochem Behav       Date:  2011-02-24       Impact factor: 3.533

2.  Angiotensin II-inhibiting drugs have no effect on intraneuronal Aβ or oligomeric Aβ levels in a triple transgenic mouse model of Alzheimer's disease.

Authors:  Linda Ferrington; J Scott Miners; Laura E Palmer; Susan M Bond; Joanne E Povey; Paul At Kelly; Seth Love; Karen J Horsburgh; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2011-02-05       Impact factor: 4.060

3.  Is heart rate variability related to memory performance in middle-aged men?

Authors:  Amit Jasvant Shah; Shaoyong Su; Emir Veledar; James Douglas Bremner; Felicia C Goldstein; Rachel Lampert; Jack Goldberg; Viola Vaccarino
Journal:  Psychosom Med       Date:  2011-06-28       Impact factor: 4.312

Review 4.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

5.  Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.

Authors:  Kun Zou; Haruyasu Yamaguchi; Hiroyasu Akatsu; Takaaki Sakamoto; Mihee Ko; Kazushige Mizoguchi; Jian-Sheng Gong; Wenxin Yu; Takayuki Yamamoto; Kenji Kosaka; Katsuhiko Yanagisawa; Makoto Michikawa
Journal:  J Neurosci       Date:  2007-08-08       Impact factor: 6.167

6.  Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia.

Authors:  Xinwu Huang; Guozhou Lu; Guochun Li; Hua Li; Beihua Li; Jiazhen Yin; Shousong Cao
Journal:  Front Neurosci       Date:  2017-06-23       Impact factor: 4.677

7.  Chronic inhibition of central Angiotensin-converting enzyme ameliorates colchicine-induced memory impairment in mice.

Authors:  Himani Awasthi; Deep Kaushal; Hefazat Husain Siddiqui
Journal:  Sci Pharm       Date:  2012-05-03

8.  The Angiotensin II Type 2 Receptor in Brain Functions: An Update.

Authors:  Marie-Odile Guimond; Nicole Gallo-Payet
Journal:  Int J Hypertens       Date:  2012-12-25       Impact factor: 2.420

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.